What Is Subchondral Bone and Why Is It Important?

Often overlooked, the bone beneath your cartilage is fundamental to joint function. Learn how changes in this layer contribute to joint pain and degeneration.

Subchondral bone is the layer of bone that sits directly beneath the cartilage inside your joints, and it acts as both a structural foundation and a biological partner for the cartilage above it. Far from being just a passive platform, subchondral bone absorbs and distributes the mechanical forces that pass through every weight-bearing joint, and it actively exchanges chemical signals with cartilage that help keep both tissues healthy. When subchondral bone starts to deteriorate or remodel abnormally, the cartilage tends to follow, which is why researchers increasingly view it as central to joint diseases like osteoarthritis.

What Subchondral Bone Actually Looks Like

If you could slice open a knee or hip joint and look at it under a microscope, you would see two distinct layers making up the subchondral region. The first is the subchondral bone plate, a relatively thin, dense shell of cortical bone that sits right under the cartilage. Just beneath that plate is a spongy zone of trabecular bone, an open lattice of tiny struts and sheets that resembles scaffolding or coral. Researchers studying this spongy layer have identified that the individual struts come in two basic shapes: plates (flat, sheet-like pieces) and rods (thinner, stick-like pieces). The ratio of plates to rods, their thickness, and the spacing between them all affect how strong the bone is and how well it handles force.

Advanced imaging studies use micro-CT scanning to measure properties of both layers. In the bone plate, researchers look at porosity (how many tiny holes run through it), thickness, and mineral density. In the trabecular zone below, they quantify the microstructure by decomposing the whole network into its individual plates and rods. These measurements matter because small changes in the architecture, even a modest thinning of trabeculae or widening of the spaces between them, can significantly weaken a joint’s ability to handle everyday loads.

How It Protects Your Joints

Every time you walk, run, or jump, force travels through your cartilage and into the subchondral bone beneath it. The spongy trabecular zone does not just passively resist that force the way a brick wall resists a push. One compelling model proposes that the fat inside the marrow spaces of subchondral bone acts as a hydraulic cushion. When you land on a joint, the impact pressurizes the marrow fat inside each small compartment. That pressure stretches the elastic walls of the surrounding trabeculae, which absorb the energy. The pressure then dissipates outward from compartment to compartment, spreading the load across a wide area rather than concentrating it at one spot. This “pressure gradient” mechanism stores energy that helps the bone spring back to shape, protecting both the bone and the cartilage above from damage.

Subchondral bone also adapts its own structure in response to loading, following the well-known principle that bone reshapes itself according to the forces placed on it. When a joint experiences higher loads over time, the cross-sectional area of the subchondral bone expands, the amount of bone tissue increases, and the trabecular network reorganizes to better support the new demands. This ability to remodel is generally helpful, but when it goes into overdrive or falls out of balance, the consequences can be severe.

The Hidden Conversation Between Cartilage and Bone

One of the most important discoveries about subchondral bone in the past two decades is that it doesn’t just support cartilage mechanically. The two tissues are in constant biochemical communication. Growth factors and signaling molecules produced in the subchondral bone can pass through the bone plate and reach the chondrocytes (the cells that maintain cartilage), influencing their behavior. This creates a feedback loop: changes in the bone alter the cartilage, and changes in the cartilage alter the bone.

As osteoarthritis progresses, abnormal remodeling in the subchondral bone increases the porosity of the bone plate and promotes the growth of new blood vessels into it. These structural changes open up channels through which even more signaling molecules flood into the cartilage, accelerating its breakdown. Lab studies have also shown that bone cells, cartilage cells, and synovial cells (the cells lining the joint capsule) can physically connect to each other through gap junction channels and directly exchange amino acids, peptides, and proteins. In other words, the joint operates as an integrated organ, and the subchondral bone is a key player in the conversation.

Why Subchondral Bone Is Central to Osteoarthritis

Osteoarthritis has traditionally been described as a disease of cartilage wearing away, but that picture is incomplete. Subchondral bone changes can appear before visible cartilage loss. Radiographic studies of hand and knee joints have shown that both the subchondral bone plate and the horizontal trabeculae underneath it thicken early in osteoarthritis, before the joint space has measurably narrowed on X-ray. In the knee, the number and extent of trabeculae increase at sites of sclerosis (hardening), yet just beneath those areas the deeper bone is actually osteoporotic, meaning less dense. As cartilage loss continues, the joint surface can become corrugated and eventually flattened and deformed.

Mouse models of accelerated aging provide another angle on this. In one study, subchondral bone changes, including a thicker bone plate, more blood vessel invasion, and higher bone volume, were dramatically higher in fast-aging mice at just six weeks of age. But cartilage damage scores didn’t catch up until fourteen weeks. The idea that subchondral bone deterioration may precede and drive cartilage loss, rather than simply accompany it, has reshaped how researchers think about treating osteoarthritis.

Nerves, Pain, and Subchondral Bone

If subchondral bone is quietly deteriorating inside your joint, how does it make itself known? Pain. Subchondral bone is densely supplied with nerves, and those nerves serve a dual purpose: they help maintain bone health through homeostatic signaling, and they carry pain signals to the brain. This is a point that surprises many people. Cartilage itself has no nerve supply, so when an arthritic joint hurts, the pain often originates in the subchondral bone, the synovial lining, or both.

In people with symptomatic osteoarthritis, researchers have found that a significantly higher proportion of cavities in the subchondral bone plate contain pain-sensing nerve fibers compared to people with the same radiographic damage but no symptoms. In other words, two people can have similar-looking joints on an X-ray, but the one with more nerve ingrowth into the subchondral bone is more likely to hurt. This helps explain a long-standing clinical puzzle: why X-ray severity and pain severity correlate so poorly in osteoarthritis.

Bone Marrow Edema and Subchondral Cysts

Two of the most common subchondral abnormalities that show up on MRI are bone marrow edema (sometimes called bone marrow lesions) and subchondral cysts. Bone marrow edema appears as a bright signal on certain MRI sequences and represents excess fluid, inflammation, or micro-damage inside the bone. It can arise from ischemic (blood-supply), mechanical (overload), or reactive (inflammatory) causes, and when left untreated in severe cases, it may progress to collapse of the joint surface.

Subchondral cysts, those fluid-filled pockets that often appear on imaging of arthritic joints, tend to develop at sites where bone marrow edema already exists. In a large longitudinal study, prevalent bone marrow lesions were associated with roughly thirteen times the odds of a new subchondral cyst forming in the same location, even after accounting for cartilage loss overhead. Cyst formation itself is thought to involve a cascade of abnormal bone turnover, new blood vessel growth, and enzyme activity breaking down the matrix, all driven by repeated mechanical insults to already-damaged tissue.

How Aging Changes the Subchondral Region

Even without disease, aging takes a measurable toll on subchondral bone. In a study of healthy femoral heads (from the hip joint), the volume of trabecular bone relative to total volume declined steadily with age, driven mostly by thinning of the individual trabeculae. The subchondral bone plate also thinned slightly over time, while the calcified cartilage layer, the thin mineralized zone at the very boundary between cartilage and bone, stayed relatively stable. On top of the structural changes, the mineral content of the subchondral bone dropped with age.

In the knee, a similar pattern appears. The medial tibial subchondral bone plate is significantly thinner in people over 69 compared to those under 40. These age-related losses likely reduce the bone’s ability to cushion and distribute loads, setting the stage for the cartilage damage that becomes more common with advancing years. When osteoarthritis does develop, the remodeling process can partially reverse this thinning in some areas by depositing excess sclerotic bone, but the quality of that new bone is often poor and its architecture disordered.

Metabolic Syndrome and Joint Health

Osteoarthritis was long considered a purely mechanical “wear-and-tear” disease. Research over the past decade has complicated that story considerably, especially regarding the role of metabolic disorders. Obesity, insulin resistance, dyslipidemia, and hypertension, the cluster sometimes called metabolic syndrome, are all independently linked to subchondral bone deterioration. These metabolic factors promote bone marrow lesions, chronic low-grade inflammation, and disrupted bone remodeling, all of which damage the subchondral zone and the cartilage it supports.

Animal studies reinforce this connection. Rats fed a diet high in saturated fat for sixteen weeks showed increased expression of cartilage-degrading enzymes in their joints and reduced bone volume in the tibial subchondral region on micro-CT imaging. The implication is that joint health is not purely a function of how much you weigh or how hard you work your joints. Your metabolic health shapes the internal biology of the subchondral bone itself.

Athletes and Repetitive Stress

In the general population, subchondral injuries tend to arise from systemic disease or acute trauma. In competitive athletes, the story is different. Chronic, repetitive microtrauma from sport-specific movements is a significant contributor to subchondral stress injuries, including stress fractures and bone death (osteonecrosis) in the subchondral zone. The distinction matters for treatment, since the underlying cause in athletes is mechanical overload rather than a vascular or metabolic process.

Studies of specific sports illustrate how loading patterns mold subchondral architecture. Research on judo athletes found that the compressive stresses, impacts, and soft-tissue pulling forces generated by lower-limb techniques produce distinctive stress distributions and bone remodeling patterns in the subchondral bone of the distal femur and tibial plateau. The bone adapts to the specific demands of the sport, which is generally helpful up to a point, but chronic overloading can push the remodeling process into territory that weakens rather than strengthens the bone.

When Blood Supply Fails

Subchondral bone depends on a reliable blood supply. When blood flow is disrupted, the bone cells die, a condition called osteonecrosis (literally “bone death”). In the hip, osteonecrosis of the femoral head is a well-studied example. Research using perfusion imaging has shown that collapse of the femoral head begins at the lateral column of the bone, precisely where the blood supply is most compromised. Once the subchondral bone loses structural integrity in that ischemic zone, the overlying cartilage surface collapses, and the joint quickly deteriorates. This is why early detection of osteonecrosis matters so much: by the time the joint surface has visibly caved in, the damage is often irreversible without surgery.

Chronic kidney disease presents another vascular-metabolic challenge. In an animal study, rats with kidney disease had significantly lower trabecular number, thinner trabeculae, and lower overall bone volume in their subchondral regions compared to healthy controls. The impaired blood flow and altered mineral metabolism that accompany kidney disease degrade the subchondral microarchitecture, which in turn threatens the cartilage above.

Tracking Subchondral Bone Damage

Clinicians have several tools for monitoring what is happening below the cartilage surface. Standard X-rays can show bone sclerosis and joint-space narrowing, but they miss early changes. MRI is far more sensitive, capable of detecting bone marrow edema, cyst formation, and even subtle structural changes before any symptoms appear. A novel micro-MRI technique for analyzing subchondral trabecular bone in hip osteoarthritis has been shown to agree well with the gold-standard micro-CT approach, with an average difference of only about 2%, opening a path to non-invasive microstructural assessment without needing a surgical sample.

Blood and urine tests are also under development. One urinary biomarker called alpha-CTX, which reflects subchondral bone turnover, has been shown to correlate strongly with the activity measured by bone scintigraphy scans and to predict future joint-space narrowing and osteophyte (bone spur) progression. In children, a normal MRI variant can mimic pathology: bright signals in the subchondral bone of the sacroiliac joint are common in prepubertal kids and reflect normal skeletal maturation, not disease. It is when that signal is asymmetric, predominantly in the ilium, or appears in older teens with closed growth plates that it raises a red flag.

Treatments Targeting Subchondral Bone

If subchondral bone remodeling drives joint disease, can slowing that remodeling protect the joint? That is exactly the rationale behind testing bisphosphonates, drugs normally used for osteoporosis, in osteoarthritis. In preclinical animal studies, bisphosphonates showed dose-dependent preservation of subchondral bone and fewer alterations in bone turnover biomarkers, with better effects at higher doses and when treatment started earlier in the disease. In a human trial of risedronate in knee osteoarthritis, higher doses maintained or increased vertical trabecular number in knees that were actively losing joint space, suggesting some protective effect on the trabecular microstructure.

The catch: a meta-analysis of randomized controlled trials found that, overall, bisphosphonates neither reliably reduced knee OA symptoms nor slowed radiographic progression. However, the authors noted that patients with high rates of subchondral bone turnover might still benefit. This disconnect between promising animal data and underwhelming clinical averages is a recurring theme in osteoarthritis research, and it hints at a future where treatments may need to be matched to individuals whose subchondral bone is actively misbehaving.

On the surgical side, several approaches try to restore subchondral bone directly. Osteochondral allografts and autologous bone grafting replace damaged bone with healthy tissue. A newer technique called subchondroplasty injects a bone substitute material into areas of bone marrow edema, sometimes combined with stem cells from the patient’s own bone marrow or fat tissue. In a small retrospective study of patients with painful bone defects in the ankle, subchondroplasty with bone marrow concentrate injection improved average pain scores from about 8 out of 10 down to under 2, and nearly all patients said they would repeat the procedure. These results are encouraging, but the studies so far are small and lack control groups, so how well these procedures hold up over the long term remains an open question.

How Evolution Shaped Subchondral Bone Across Species

Comparing subchondral bone across the animal kingdom reveals just how tightly its design is linked to how an animal moves. In mammals, as body size increases, joints become more tightly fitted (more congruent), the articular cartilage gets thinner relative to body size, and the subchondral region narrows with sharper surface features. In contrast, saurischian dinosaurs, the lineage that includes sauropods and theropods, scaled up in an entirely different way: their joints remained gently convex, their cartilage stayed thick, and the sub-articular bone expanded outward. Researchers have suggested this difference may be one reason gigantism was rarer in mammals. Thin cartilage on an increasingly congruent joint can only distribute so much stress before it fails, setting an upper limit on size.

Even more striking are the differences between land-dwelling and aquatic mammals. Marine mammals like whales and dolphins have cartilage with a nearly random internal fiber arrangement rather than the organized, layered architecture found in land animals. Their subchondral bone plate is extremely thin and highly porous, and they lack the calcified cartilage layer entirely. Their cartilage is also considerably less stiff. These adaptations make sense: buoyancy removes much of the gravitational loading that terrestrial joints must handle, so the entire subchondral system can afford to be lighter and more flexible. The fact that aquatic mammals shed the structural complexity their land-dwelling ancestors needed underscores the point that subchondral bone exists, first and foremost, to accommodate mechanical load.

The Growth Plate Connection in Children

Subchondral bone plays a special role during skeletal development. In growing children, the growth plate, the zone of cartilage responsible for bone elongation, actually has two interfaces with bone rather than one. On the epiphyseal side (the end nearest the joint surface), the reserve zone of the growth plate connects to a thin plate of subchondral bone. This junction resembles the interface between adult articular cartilage and bone, though far less is known about its composition and how it forms. Understanding this interface matters because injuries or diseases that disrupt it during childhood can affect not only bone growth but also the quality of the subchondral bone that eventually supports the adult joint surface. It is another reminder that what happens in the subchondral zone, whether during development, daily activity, or disease, reverberates throughout the entire joint.